Latest Breaking News On - Exchange commission the offering - Page 3 : comparemela.com

ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / June 9, 2021 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin® therapeutics

New yorkUnited statesShai biranSeth lewisThomas schneckenburgerBroadridge financial solutionsSwiss stock exchangeJp morgan securitiesKempen coInternational reporting standardSwiss exchangeExchange commissionProspectus departmentBroadridge financial servicesExchange commission the offeringSyndicate department